Education
About Us
Working with TipRanks
Follow Us
MetaVia (MTVA)
NASDAQ:MTVA
Da-1726
Obesity
Phase I
Recruiting
First in Human Study in Subjects With Obesity, But Otherwise Healthy
Jan 09, 2024
―
Sitagliptin, Da-1241
Non-Alcoholic Steatohepatitis
Phase II
Completed
Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH
Sep 05, 2023
―
Niclosamide
Healthy
Phase I
Completed
A Single and Multiple Ascending Dose Study of Niclosamide in Healthy Volunteers
Dec 08, 2020
―
Niclosamide
Covid-19
Phase II/III
Completed
Study of Niclosamide in Moderate and Severe Hospitalized Coronavirus-19 (COVID-19) Patients
Oct 20, 2020
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does MetaVia (MTVA) have in its pipeline
MTVA is currently developing the following drugs: Da-1726, Sitagliptin, Da-1241, Niclosamide. These drug candidates are in various stages of clinical development as the company works toward FDA approval.